Not all intravenous immunoglobulin preparations are equally well tolerated.
about
Clinical Experience with Octagam® 10 %, a solvent detergent virus inactivated intravenous immunoglobulin: a Canadian retrospective review of utilizationRecent Progress towards Novel EV71 Anti-Therapeutics and VaccinesCutaneous dermatomyositis: an updated review of treatment options and internal associations.Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin GHuman normal immunoglobulin in the treatment of primary immunodeficiency diseases.Special considerations with the use of intravenous immunoglobulin in older persons.Improving patient tolerability in immunoglobulin treatment: focus on stabilizer effects.Pattern of intravenous immunoglobulins (IVIG) use in a pediatric intensive care facility in a resource limited setting.Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practice.Evidence-based strategies to reduce intravenous immunoglobulin-induced headaches.Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study.Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy.Adverse Effects of Immunoglobulin Therapy.
P2860
Q26741124-E1719761-75E2-4D61-949C-067D1F3808D9Q26775734-B988917A-92D8-40A8-8CB9-6B3C722CD0F5Q34349952-AC0C8162-9A75-4826-80E0-4F64F44A8B7FQ35803387-53B02D1D-62EF-4C4F-9E52-FAE296502327Q35905557-99F472F6-11CB-4FFB-8C7A-E3D2992D4523Q37931231-8A51CFE9-4ADE-4F1C-8B27-F0C27673F9A0Q38111424-634F3F13-3864-4BF1-A6F1-57018FA218F3Q38162842-7922C4E2-0340-43CC-B6AA-79E555156C98Q38221095-B922FC58-D7B3-46A9-A4B4-B0A6366C6B54Q38297114-6D7E0E41-28C4-471A-BB57-AB250B0BE704Q38372260-02076ED3-0718-4E0D-80AA-AABEDD5C0F46Q38637766-B274FC57-3587-4CAC-94E4-03C4D8B3B6C7Q47217747-21691B8F-3B28-47DA-84A8-DEA359A7E339Q55465940-8B569EA9-AC1E-43A6-938F-A20B5ECF68DC
P2860
Not all intravenous immunoglobulin preparations are equally well tolerated.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Not all intravenous immunoglobulin preparations are equally well tolerated.
@en
type
label
Not all intravenous immunoglobulin preparations are equally well tolerated.
@en
prefLabel
Not all intravenous immunoglobulin preparations are equally well tolerated.
@en
P2093
P50
P356
P1476
Not all intravenous immunoglobulin preparations are equally well tolerated
@en
P2093
Annette Boehler
Christian Benden
Laurence Feldmeyer
Rudolf Speich
P304
P356
10.2340/00015555-0900
P577
2010-09-01T00:00:00Z